Lyme Disease Diagnostic Devices Market Size, Growth, Demands Outlook and Forecasts to 2027

According to the research report, the global lymedisease diagnostic devices market size is expected to touch USD 3.87 Billion by 2027, from USD 2.03 Billion in 2019, growing with a significant CAGR of 7.2% from 2020 to 2027.

Lyme Disease Diagnostic Devices Market Size 2016 to 2027

The lyme disease diagnostic devices market report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global lyme disease diagnostic devices market in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global lyme disease diagnostic devices market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global lyme disease diagnostic devices market during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1183

Report Scope of the Lyme Disease Diagnostic Devices Market

Report Highlights	Details
Market Size	USD 3.87 billion by 2027
Growth Rate	CAGR of 7.2% From 2021 to 2027
Largest Market	North America
Fastest Growing Market	Asia Pacific
Base Year	2021
Forecast Period	2021 to 2027
Segments Covered	Product, End User, Region

This study covers a detailed segmentation of the global lyme disease diagnostic devices market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global lyme disease diagnostic devices market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific, Inc.
Boulder Diagnostics
T2 Biosystems, Inc.
Abbott
Oxford Immunotec Global PLC
Quidel Corporation
Affymetrix Inc.
Hoffmann-La Roche Ltd
Graphene Frontiers

Market Segmentation

By Product Type

Serological Test
Urine Antigen Tests
Lymphocytic Transformation Test
Immunofluorescent Staining
Nucleic acid Test

By End User

Hospitals
Public/Private Laboratories
Physician’s Office

By Geography

North America

U.S.
Canada

Europe

Germany
France
United Kingdom
Rest of Europe

Asia Pacific

China
Japan
India
Southeast Asia
Rest of Asia Pacific

Latin America

Brazil
Rest of Latin America

Middle East & Africa (MEA)

GCC
North Africa
South Africa
Rest of Middle East & Africa

Research Methodology

The research methodology adopted by analysts for compiling the global lyme disease diagnostic devices market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global lyme disease diagnostic devices market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. DataSources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Lyme End User Diagnostic Devices Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Lyme End User Diagnostic Devices Market

5.1. Covid-19: Lyme End User Diagnostic Devices Industry Impact
5.2. Lyme End User Diagnostic Devices Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Lyme End User Diagnostic Devices Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Lyme End User Diagnostic Devices Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Lyme End User Diagnostic Devices Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Growing prevalence of Lyme disease
6.1.1.2. Growing investment in research and development
6.1.2. Market Restraints
6.1.2.1. Lack of awareness
6.1.3. Market Opportunities
6.1.3.1. Technological advancements

Chapter 7. Global Lyme End User Diagnostic Devices Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Lyme End User Diagnostic Devices Market Revenue by Market Players (2016 -2019)
7.1.1.2. Lyme End User Diagnostic Devices Market Revenue Market Share by Market Players (2016 -2019)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Type Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Lyme End User Diagnostic Devices Market, By Product Type

8.1. Lyme End User Diagnostic Devices Market, by Product Type, 2016-2027
8.1.1. Serological Test
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Urine Antigen Tests
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Lymphocytic Transformation Test
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Immunofluorescent Staining
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Nucleic Acid Test
8.1.5.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global Lyme End User Diagnostic Devices Market, By End User

9.1. Lyme End User Diagnostic Devices Market, by End User, 2016-2027
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Public/Private Laboratories
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Physician’s Office
9.1.3.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global Lyme End User Diagnostic Devices Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue Forecast by Product Type(2016-2027)
10.1.2. Market Revenue Forecast by End User (2016-2027)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2016-2027)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2016-2027)
10.2. Europe
10.2.1. Market Revenue Forecast by Product Type (2016-2027)
10.2.2. Market Revenue Forecast by End User (2016-2027)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2016-2027)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2016-2027)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2016-2027)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2016-2027)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Product Type (2016-2027)
10.3.2. Market Revenue Forecast by End User (2016-2027)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2016-2027)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2016-2027)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2016-2027)
10.4. LATAM
10.4.1. Market Revenue Forecast by Product Type (2016-2027)
10.4.2. Market Revenue Forecast by End User (2016-2027)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2016-2027)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2016-2027)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Product Type (2016-2027)
10.5.2. Market Revenue Forecast by End User (2016-2027)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2016-2027)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2016-2027)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2016-2027)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2016-2027)

Chapter 11. Company Profiles

11.1. Bio-Rad Laboratories, Inc.
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, End User
11.1.3. Revenue, Price, and Gross Margin (2015-2020)
11.1.4. Recent Developments and Strategies
11.2. Thermo Fisher Scientific, Inc.
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, End User
11.2.3. Revenue, Price, and Gross Margin (2015-2020)
11.2.4. Recent Developments and Strategies
11.3. Boulder Diagnostics
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, End User
11.3.3. Revenue, Price, and Gross Margin (2015-2020)
11.3.4. Recent Developments and Strategies
11.4. T2 Biosystems, Inc.
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, End User
11.4.3. Revenue, Price, and Gross Margin (2015-2020)
11.4.4. Recent Developments and Strategies
11.5. Abbott
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, End User
11.5.3. Revenue, Price, and Gross Margin (2015-2020)
11.5.4. Recent Developments and Strategies
11.6. Oxford Immunotec Global PLC
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, End User
11.6.3. Revenue, Price, and Gross Margin (2015-2020)
11.6.4. Recent Developments and Strategies
11.7. Quidel Corporation
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, End User
11.7.3. Revenue, Price, and Gross Margin (2015-2020)
11.7.4. Recent Developments and Strategies
11.8. Affymetrix Inc.
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, End User
11.8.3. Revenue, Price, and Gross Margin (2015-2020)
11.8.4. Recent Developments and Strategies
11.9. F. Hoffmann-La Roche Ltd
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, End User
11.9.3. Revenue, Price, and Gross Margin (2015-2020)
11.9.4. Recent Developments and Strategies
11.10. Graphene Frontiers
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, End User
11.10.3. Revenue, Price, and Gross Margin (2015-2020)
11.10.4. Recent Developments and Strategies